Haier Biomedical: a total of 84.1156 million yuan has been repurchased for employee incentives.

Haier Biological announced that the company repurchased shares through centralized bidding trading on January 13, 2025, with a repurchase fund of 100 million to 200 million yuan, for use in employee shareholding plans or equity incentives, with a deadline of January 13, 2026. As of October 31, 2025, a total of 2.5903 million shares have been repurchased, accounting for 0.8147% of the total share capital, with a repurchase amount of 84.1156 million yuan, and repurchase prices ranging from 29.86 to 34.69 yuan per share.